Literature DB >> 14754735

Chondrocyte viability in refrigerated osteochondral allografts used for transplantation within the knee.

Albert W Pearsall1, J Allan Tucker, Raymond B Hester, Robert J Heitman.   

Abstract

PURPOSE: To evaluate cell viability and matrix characteristics of refrigerated osteochondral allografts implanted up to 44 days after harvest.
METHODS: Sixteen refrigerated allografts underwent histologic and ultrastructural examination and fluorescence excitation analysis prior to implantation. The average size of the graft implanted was 6.2 cm(2) (+/-3.4 cm(2)). Refrigerated allografts averaged 30 days (range, 17 to 44 days) from donor expiration to implantation. Nine specimens underwent cell viability testing. The percent viability of refrigerated allografts prior to implantation averaged 67%.
RESULTS: No significant correlations were noted between histologic score, electron microscopy score, matrix staining percent (MSP) score, and viability. When time to implantation was assessed, an inverse correlation was noted with MSP score (r =.539) (P < 0.05), indicating less matrix staining in grafts refrigerated longer after harvest.
CONCLUSION: The current data indicate that refrigerated osteochondral allografts can be maintained for up to 44 days with average chondrocyte viability of 67%.

Entities:  

Mesh:

Year:  2004        PMID: 14754735     DOI: 10.1177/0095399703258614

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  32 in total

1.  Allogenic serum improves cold preservation of osteochondral allografts.

Authors:  Kenji Onuma; Ken Urabe; Kouji Naruse; Kentaro Uchida; Moritoshi Itoman
Journal:  Clin Orthop Relat Res       Date:  2011-11-18       Impact factor: 4.176

Review 2.  Osteochondritis Dissecans: Etiology, Pathology, and Imaging with a Special Focus on the Knee Joint.

Authors:  Juergen Bruns; Mathias Werner; Christian Habermann
Journal:  Cartilage       Date:  2017-06-22       Impact factor: 4.634

3.  Repair of massively defected hemi-joints using demineralized osteoarticular allografts with protected cartilage.

Authors:  Siming Li; Xiaohong Yang; Shenghui Tang; Xunmeng Zhang; Zhencheng Feng; Shuliang Cui
Journal:  J Mater Sci Mater Med       Date:  2015-08-30       Impact factor: 3.896

4.  Why Do Osteochondral Allografts Survive? Comparative Analysis of Cartilage Biochemical Properties Unveils a Molecular Basis for Durability.

Authors:  Lei Ding; Biagio Zampogna; Sebastiano Vasta; Kee Woong Jang; Francesca De Caro; James A Martin; Annunziato Amendola
Journal:  Am J Sports Med       Date:  2015-08-26       Impact factor: 6.202

5.  Material properties of fresh cold-stored allografts for osteochondral defects at 1 year.

Authors:  Anil S Ranawat; Armando F Vidal; Chris T Chen; Jonathan A Zelken; A Simon Turner; Riley J Williams
Journal:  Clin Orthop Relat Res       Date:  2008-06-05       Impact factor: 4.176

6.  The use of osteochondral allografts in the management of cartilage defects.

Authors:  Marco Demange; Andreas H Gomoll
Journal:  Curr Rev Musculoskelet Med       Date:  2012-09

7.  Updates in biological therapies for knee injuries: full thickness cartilage defect.

Authors:  Alexandre Pedro Nicolini; Rogerio Teixeira Carvalho; Bruno Dragone; Mario Lenza; Moises Cohen; Mario Ferretti
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09

8.  Open traumatic osteochondral fracture of the femoral medial condyle and trochlea treated by mosaicplasty: a case report at 11-year follow-up.

Authors:  Christian Carulli; Fabrizio Matassi; Stefano Soderi; Lorenzo Nistri; Roberto Civinini; Massimo Innocenti
Journal:  HSS J       Date:  2014-08-29

Review 9.  [Non-cryoconserving storage strategies for fresh osteochondral allografts].

Authors:  Luisa Marilena Schäck; Jan-Dierk Clausen; Sandra Noack; Afif Harb; Christian Krettek; Claudia Neunaber
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

10.  Do fresh osteochondral allografts successfully treat femoral condyle lesions?

Authors:  Yadin D Levy; Simon Görtz; Pamela A Pulido; Julie C McCauley; William D Bugbee
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.